Skye Bioscience Long Term Deferred Charges (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.8002 +0.02 (+2.39%) USD | NASDAQ | Feb 23, 16:00

0.8002 0.00 (0.00%) Pre-Market: 08:33

View Long Term Deferred Charges (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Merck & Co., Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--